(Total Views: 365)
Posted On: 12/22/2019 9:54:01 AM
Post# of 154905
The ROI is irrespective of the needs or wants of an individual investor.
Yes, time as a variable should be considered in any discussion of ROI. Will the ROI from the company your invested in outperform other potential investments in a determined time period.
For a BO anytime soon will any company offer us even close to the potential peak in CYDY? Will a larger company's share price appreciate at the same rate or even close to CYDY?
It all comes down to where you think the share price is going and at what rate. For CYDY it becomes what indications will be approved, when and the number of scripts.
The science backs up a wide array of indications. Once we're into revenue we can launch multiple trials. Even if the FDA won't approve early we should start really kicking ass within 3 1/2 - 4 years. With early approval knock a year off from that.
I fully expect a $100 share price at that time. At the current share price that's a 17,241% return on investment. Will any other companies shares equal that ROI in that time frame? Personally I don't think so.
With a stock swap the revenue generated by the other company is subsumed by revenue that already exists. Although you'll see a hard jump up in the stock price it will be a fraction of what would happen with CYDY itself.
Yes, time as a variable should be considered in any discussion of ROI. Will the ROI from the company your invested in outperform other potential investments in a determined time period.
For a BO anytime soon will any company offer us even close to the potential peak in CYDY? Will a larger company's share price appreciate at the same rate or even close to CYDY?
It all comes down to where you think the share price is going and at what rate. For CYDY it becomes what indications will be approved, when and the number of scripts.
The science backs up a wide array of indications. Once we're into revenue we can launch multiple trials. Even if the FDA won't approve early we should start really kicking ass within 3 1/2 - 4 years. With early approval knock a year off from that.
I fully expect a $100 share price at that time. At the current share price that's a 17,241% return on investment. Will any other companies shares equal that ROI in that time frame? Personally I don't think so.
With a stock swap the revenue generated by the other company is subsumed by revenue that already exists. Although you'll see a hard jump up in the stock price it will be a fraction of what would happen with CYDY itself.
(2)
(0)
